A statistical method for judging synergism: Application to an endocrine disruptor animal experiment

Environmetrics

Volumn 14, Issue 2, 2003, Pages 213-222

  Matsunaga, Nobuhito ^a   Kanno, Jun ^b   Yoshimura, Isao ^c  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Animal experiment; Design of experiment; Endocrine disruptor; Statistical test; Synergism

Indexed keywords

EXPERIMENT; METHODOLOGY; STATISTICAL ANALYSIS;

ANIMALIA; RODENTIA;

EID: 0037356987     PISSN: 11804009     EISSN: None     Source Type: Journal    
DOI: 10.1002/env.578     Document Type: Conference Paper

References (21)

1. Berenbaum MC. 1989. What is synergy? Pharmacological Reviews 41: 93-141.
2. Committee on hormonally active agents in the environment, board on environmental studies and toxicology, commission on life sciences, National Research Council. 1999. Hormonally Active Agents in the Environment. National Academy Press: Washington, DC.
3. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC). 2001. Final Report. http://www.epa.gov/oscpmont/oscpendo/hisorty/finalrpt.htm.
4. Gennings C, Schwarz P, Carter WH, Simmons JE. 1997. Detection of departures from additivity in mixtures of many chemicals with a threshold model. Jour. Agri. Biol. Environ. Stat. 2: 198-211.
5. Hasegawa R, Yoshimura I, Imaida K, Ito N, Shimi T. 1996. Analysis of synergism in hepatocarcinogenesis based on preneoplastic foci induction by 10 heterocyclic amines in the rat. Jpn Jour. Cancer Res. 87: 1125-1133.
6. Hewlett PS, Placket RL. 1959. A unified theory for quantal response to mixtures of drugs: noninteractive action. Biometrics 15: 591-610.
7. Kanno J, Onyon L, Haseman J, Fenner-Crisp P, Ashby J, Owens W. 2001. The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: Phase 1. Environmental Health Perspectives 109: 785-794.
8. Kodell RL, Pounds JG. 1990. Assessing the toxicity of mixtures of chemicals. In Stat. in Tox., Krewski D, Franklin C (eds). Gordon and Breach Science Publishers, Chapter 26: 559-591.
9. Laska EM, Meisner M, Ang DI. 1997. Classification of the effectiveness of combination treatments. Stat. in Med. 16: 2211-2228.
10. Laurence DR, Bennett PN. 1980. Clinical Pharmacology (5th edn). Churchill Livingstone; 162-163.
11. Machado SG, Robinson GA. 1994. A direct, general approach based on isobologram for assessing the joint action of drugs in pre-clinical experiment. Stat. in Med. 13: 2289-2309.
12. Piegorsch WW, Bailer AJ. 1997. Statistics for Environmental Biology and Toxicology. Chapman & Hall: London.
13. Reif AE. 1984. Synergism in carcinogenesis. Jour. National Cancer Inst. 73: 25-39.
14. Rothman KJ, Greenland S, Walker AM. 1980. Concept of interaction. Amer. Jour. Epidemiology 112: 467-470.
15. Roy P, Esteve J. 1998. Using relative risk models for estimating synergy between two risk factors. Stat. Med. 17: 1357-1373.
16. Sakuma A. 1996. The World of Sakuma Akira. Scientist, Tokyo. 27-29 (in Japanese).
17. Saracct R. 1980. Interaction and synergism. Stat. Med. 17: 1357-1373.
18. Satterthwaite FE. 1946. An approximate distribution of estimates of variance components. Biometrics 2: 110-114.
19. Solicitation of Comments on Proposed Peer Review of Low-dose Issues for Endocrine Disruptors. 2001. http://ntpserver.hiehs.nih.gov/htdocs/liason/LowDoseEndocrineFR.html; http://ntpserver.hiehs.nih.gov/htdocs/liason/EndocrineMtgDelayFR.html
20. Welch BL. 1938. The significance of the difference between two means when the population variances are unequal. Biometrika 29: 350-362.
21. Yamasaki K, Takeyoshi M, Yakabe Y, Sawaki M, Imatanaka N, Takatsuki M. 2002. Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals. Toxicology 170: 21-30.